Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review
Helen Giamarellou, Lamprini Galani, Theodoros Karavasilis, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1557-1557
Open Access | Times Cited: 30
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 7, pp. 843-852
Open Access | Times Cited: 23
Streptomyces monashensis MSK03-mediated synthesis of gold nanoparticles: characterization and antibacterial activity
Supavadee Kerdtoob, Panjamaphon Chanthasena, A’liyatur Rosyidah, et al.
RSC Advances (2024) Vol. 14, Iss. 7, pp. 4778-4787
Open Access | Times Cited: 10
Evolution of Antibiotic Resistance in Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Multi-Profile Hospital over 5 Years (2017–2021)
Beata Mączyńska, Magdalena Frej−Mądrzak, Jolanta Sarowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2414-2414
Open Access | Times Cited: 13
China’s plan to combat antimicrobial resistance
Xinyang Li, Yuye Wu, Tian Jiang, et al.
Science (2024) Vol. 383, Iss. 6690, pp. 1424-1425
Closed Access | Times Cited: 5
Update on the Management of Surgical Site Infections
Biagio Pinchera, Antonio Riccardo Buonomo, Nicola Schiano Moriello, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1608-1608
Open Access | Times Cited: 19
Intrahospital dissemination of multidrug-resistant Acinetobacter baumannii at a teaching hospital in Northeast of Mexico
Samantha Villarreal-Cruz, Adrián Camacho-Ortíz, Samantha Flores-Treviño, et al.
Infection Prevention in Practice (2025), pp. 100443-100443
Open Access
The Evolving Landscape of Infective Endocarditis: Difficult-to-Treat Resistance Bacteria and Novel Diagnostics at the Foreground
Vasiliki Rapti, Efthymia Giannitsioti, Nikolaos Spernovasilis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2087-2087
Open Access
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses
Kathleen P. Davis, Yoelkys Morales, Rachel J. Ende, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 3
Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+
Mateusz Szymański, Małgorzata M. Skiba, Małgorzata Piasecka, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 2307-2313
Open Access | Times Cited: 3
The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
Natalia G. Vallianou, Alexandros Skourtis, Dimitris Kounatidis, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 140-140
Open Access | Times Cited: 6
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
Arsheena Yassin, Mariya Huralska, Jason M. Pogue, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 9, pp. e46-e56
Open Access | Times Cited: 5
Antibiotics profile map of clinical A. baumannii strains isolated from health institutions in Turkey: a database search study and analysis of publications from 2011 to 2022
Ahmed Badri Abed, Safiye Elif Korcan, Serdar Güngör
Bulletin of the National Research Centre/Bulletin of the National Research Center (2023) Vol. 47, Iss. 1
Open Access | Times Cited: 4
Peptaibol Analogs Show Potent Antibacterial Activity against Multidrug Resistant Opportunistic Pathogens
Chiara Dalla Torre, Filomena Sannio, Mattia Battistella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7997-7997
Open Access | Times Cited: 4
Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico
Adrián Camacho-Ortíz, Samantha Flores-Treviño, Paola Bocanegra‐Ibarias
Infection Prevention in Practice (2024) Vol. 7, Iss. 1, pp. 100426-100426
Open Access | Times Cited: 1
An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options
Jiaju Zhuo, Beibei Liang, Huan Zhang, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 11, pp. 1203-1212
Closed Access | Times Cited: 3
Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae
Lisa Allander, Karin Vickberg, Pernilla Lagerbäck, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1646-1646
Open Access | Times Cited: 5
Off-Label Use of Ceftazidime/Avibactam for the Treatment of Pan-Drug-Resistant Klebsiella pneumoniae in a Neonate: Case Report and Literature Review
Iliya Mangarov, Ралица Георгиева, Valentina Petkova, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1302-1302
Open Access | Times Cited: 2
Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR Acinetobacter baumannii and Literature Review
Ioanna Tatouli, N Dedes, Andreas Bozikas, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1382-1382
Open Access
Retrospective analysis of Acinetobacter baumannii bacteraemia risk factors, complications and mortality in a tertiary university hospital in Saudi Arabia
Reham Kaki
Access Microbiology (2024) Vol. 6, Iss. 9
Open Access
Antibacterial Activity of Azanza garckeana extracts (Malvaceae) in vitro and Their Potential Use in Respiratory Infections
Ruvarashe Dakwa, Winnie Mozirandi, Stanley Mukanganyama
Microbial Pathogenesis (2024), pp. 107170-107170
Closed Access
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria
Matteo Bersani, Mariacristina Failla, Filippo Vascon, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1682-1682
Open Access | Times Cited: 1
Year 2022 in review - Sepsis
Thomas Karvunidis, Martin Matějovič
Anesteziologie a intenzivní medicína (2022) Vol. 33, Iss. 6, pp. 256-259
Closed Access | Times Cited: 1
Editorial for Special Issue “Antimicrobial Therapy in Intensive Care Unit”
E. Paramythiotou, Christina Routsi
Antibiotics (2023) Vol. 12, Iss. 2, pp. 278-278
Open Access
VAP Causative Agents During COVID-19 Pandemic Era: Narrative Review
Usha Rani Kandula, Techane Sisay Tuji, Anwar Abdulwahed, et al.
Current Respiratory Medicine Reviews (2023) Vol. 19, Iss. 3, pp. 202-217
Closed Access
Page 1

Scroll to top